| Literature DB >> 20541695 |
Jill Slack-Davis1, John O Dasilva, Sarah J Parsons.
Abstract
In this issue of Cancer Cell, Carretero and colleagues report that Src and FAK signaling pathways are activated in lung cancers when the tumor suppressor LKB1 is deleted. These findings suggest the use of unique combinatorial therapies for treatment of lung cancers. Copyright 2010 Elsevier Inc. All rights reserved.Entities:
Year: 2010 PMID： 20541695 DOI： 10.1016/j.ccr.2010.05.016
Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 31.743